The US FDA has recently issued a final rule that establishes regulations to require current good manufacturing practices (cGMP) for dietary supplements and ensures that dietary supplements are produced in a quality manner, do not contain contaminants or impurities, and are accurately labeled.
According to Commissioner of Food and Drugs Andrew C. von Eschenbach, M.D.:
“This rule helps to ensure the quality of dietary supplements so that consumers can be confident that the products they purchase contain what is on the label. In addition, as a result of recent amendments to the Federal Food, Drug, and Cosmetic Act, by the end of the year, industry will be required to report all serious dietary supplement related adverse events to FDA.”
The final CGMP and the interim final rule are effective August 24, 2007.